Announcements
- IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd
- IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
- IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
- IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.
- IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue
- IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference
- IRADIMED CORPORATION Announces Establishment of a Quarterly Dividend of $0.15 per share and a Special Cash Dividend of $0.48 per share
- IRADIMED CORPORATION Named a 2024 Most Successful Small-Cap Company in America by Forbes
- IRADIMED CORPORATION Announces Third Quarter 2023 Financial Results
- IRADIMED CORPORATION to Hold 2023 Third Quarter Financial Results Conference Call on November 3rd
More ▼
Key statistics
As of last trade IRadimed Corp (46K:DUS) traded at 38.40, -3.03% below its post-IPO high of 39.60, set on Apr 24, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 38.60 |
---|---|
High | 38.60 |
Low | 38.40 |
Bid | 38.60 |
Offer | 39.80 |
Previous close | 37.80 |
Average volume | 0.00 |
---|---|
Shares outstanding | 12.66m |
Free float | 7.97m |
P/E (TTM) | 31.10 |
Market cap | 531.84m USD |
EPS (TTM) | 1.35 USD |
Data delayed at least 15 minutes, as of May 02 2024 08:31 BST.
More ▼